Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Exagen (XGN) Net Income (2018 - 2025)

Exagen (XGN) has disclosed Net Income for 8 consecutive years, with -$6.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Net Income fell 67.38% year-over-year to -$6.3 million, compared with a TTM value of -$21.5 million through Dec 2025, down 42.46%, and an annual FY2025 reading of -$20.0 million, down 31.99% over the prior year.
  • Net Income was -$6.3 million for Q4 2025 at Exagen, up from -$7.1 million in the prior quarter.
  • Across five years, Net Income topped out at -$3.0 million in Q2 2024 and bottomed at -$15.1 million in Q4 2022.
  • Average Net Income over 5 years is -$6.8 million, with a median of -$6.2 million recorded in 2021.
  • The sharpest move saw Net Income plummeted 128.86% in 2022, then soared 65.83% in 2023.
  • Year by year, Net Income stood at -$7.1 million in 2021, then crashed by 114.33% to -$15.1 million in 2022, then skyrocketed by 63.35% to -$5.5 million in 2023, then soared by 32.33% to -$3.7 million in 2024, then plummeted by 67.38% to -$6.3 million in 2025.
  • Business Quant data shows Net Income for XGN at -$6.3 million in Q4 2025, -$7.1 million in Q3 2025, and -$4.4 million in Q2 2025.